These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 4580889

  • 1. Evaluation of antilymphocyteserum: comparison of skinallograft survival and rosette inhibition.
    Kissling M, Speck B.
    Experientia; 1973 May 01; 29(1):105-6. PubMed ID: 4580889
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ, Wood ML, Monaco AP.
    Transplantation; 1972 Sep 01; 14(3):352-7. PubMed ID: 4564931
    [No Abstract] [Full Text] [Related]

  • 4. Antibody titres of antilymphocytic sera and globulins determined by immunofluorescence and their correlation with immunosuppressive activity.
    Thomas D, Woodrooffe JG, Mosedale B, Ward PD, Zola H, Edwards DC, Balner H.
    Clin Exp Immunol; 1972 Aug 01; 11(4):569-78. PubMed ID: 4628577
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of phytohemagglutinin and antilymphocyte serum on the survival time of homologous skin grafts in mice].
    Kaden J, Kaden K.
    Z Exp Chir; 1973 Aug 01; 6(6):401-9. PubMed ID: 4152194
    [No Abstract] [Full Text] [Related]

  • 7. [Rosette formation inhibition test in allotransplantation of the kidney in the clinic].
    Polishchuk RV, Korenevskaia VA, Goriainov VA.
    Klin Khir (1962); 1973 Dec 01; 12():35-41. PubMed ID: 4596530
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. "In vivo" standardization model for defining the dose-response-dependent graft-protective value of antilymphocyte sera.
    Réthy L, Osz E.
    Dev Biol Stand; 1974 Dec 01; 27():233-5. PubMed ID: 4618536
    [No Abstract] [Full Text] [Related]

  • 10. Homograft rejection delayed by treatment of donor tissue in vitro with antilymphocyte serum.
    Burde RM, Waltman SR, Berrios JH.
    Science; 1971 Sep 03; 173(4000):921-3. PubMed ID: 4937230
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antithymocyte globulin (ATG) and trenimon (TR): effects on T cells and graft rejection.
    Beatty JD, Friesen E, Linford JH, Israels LG.
    Surg Forum; 1977 Sep 03; 28():327-9. PubMed ID: 364726
    [No Abstract] [Full Text] [Related]

  • 14. Studies on antilymphocyte serum and transplantation immunity in Syrian hamsters.
    Shaffer CF, Streilein JW, Freedberg PS, Sherman J.
    Transplantation; 1971 Apr 03; 11(4):396-403. PubMed ID: 4934350
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of tolerance with antilymphocytic serum.
    Lance EM, Medawar PB.
    Transplant Proc; 1969 Mar 03; 1(1):429-32. PubMed ID: 4944254
    [No Abstract] [Full Text] [Related]

  • 17. Mode of recovery from the effects of heterologous anti-lymphocyte serum. I. Recovery of the immune response.
    Jeejeebhoy HF, Singla O.
    Immunology; 1972 May 03; 22(5):789-99. PubMed ID: 4553773
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.